(-)-demecolcine increases expression ISO RGD:1352815 6480464 Demecolcine results in increased expression of SOCS2 mRNA CTD PMID:23649840 (1->4)-beta-D-glucan multiple interactions ISO RGD:1332166 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SOCS2 mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression ISO RGD:1332166 6480464 ethylene dichloride results in decreased expression of SOCS2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1332166 6480464 1, 2-Dimethylhydrazine results in decreased expression of SOCS2 mRNA CTD PMID:22206623 1,3-dinitrobenzene decreases expression EXP 6480464 3-dinitrobenzene results in decreased expression of SOCS2 mRNA CTD PMID:22841810 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of SOCS2 mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO RGD:1332166 6480464 Estradiol results in increased expression of SOCS2 mRNA CTD PMID:19484750 , PMID:25210133 17beta-estradiol decreases expression ISO RGD:1352815 6480464 Estradiol results in decreased expression of SOCS2 mRNA CTD PMID:31614463 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of SOCS2 mRNA CTD PMID:32145629 17beta-estradiol increases expression ISO RGD:1352815 6480464 Estradiol results in increased expression of SOCS2 mRNA CTD PMID:17272397 , PMID:21795739 17beta-estradiol multiple interactions ISO RGD:1352815 6480464 [Estradiol co-treated with Progesterone] results in increased expression of SOCS2 mRNA CTD PMID:20660070 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO RGD:1352815 6480464 Metribolone results in increased expression of SOCS2 mRNA CTD PMID:16751804 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1352815 6480464 Dihydrotestosterone results in increased expression of SOCS2 mRNA CTD PMID:29581250 2,2',4,4',5,5'-hexachlorobiphenyl affects expression ISO RGD:1332166 6480464 2 more ... CTD PMID:24680724 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1332166 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1332166 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1332166 6480464 AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of SOCS2 mRNA] more ... CTD PMID:15371557 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SOCS2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SOCS2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1332166 6480464 Tetrachlorodibenzodioxin results in decreased expression of SOCS2 mRNA CTD PMID:18372398 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1332166 6480464 Tetrachlorodibenzodioxin affects the expression of SOCS2 mRNA CTD PMID:18343893 , PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1352815 6480464 Tetrachlorodibenzodioxin results in increased expression of SOCS2 mRNA CTD PMID:19692669 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1352815 6480464 Tetrachlorodibenzodioxin affects the expression of SOCS2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1332166 6480464 Tetrachlorodibenzodioxin results in increased expression of SOCS2 mRNA, Tetrachlorodibenzodioxin results in increased expression of SOCS2 protein CTD PMID:15371557 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:1332166 6480464 2 more ... CTD PMID:18343893 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1332166 6480464 3 more ... CTD PMID:15371557 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1352815 6480464 3 more ... CTD PMID:19692669 3-methylcholanthrene multiple interactions ISO RGD:1332166 6480464 [Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of SOCS2 mRNA CTD PMID:25926378 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of SOCS2 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of SOCS2 mRNA CTD PMID:25380136 4-hydroxyphenyl retinamide decreases expression ISO RGD:1332166 6480464 Fenretinide results in decreased expression of SOCS2 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression ISO RGD:1332166 6480464 Fenretinide results in increased expression of SOCS2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:1352815 6480464 Decitabine affects the expression of SOCS2 mRNA CTD PMID:23300844 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SOCS2 mRNA CTD PMID:25825206 9-cis-retinoic acid increases expression ISO RGD:1352815 6480464 Alitretinoin results in increased expression of SOCS2 mRNA CTD PMID:15982314 acetylsalicylic acid increases expression ISO RGD:1332166 6480464 Aspirin results in increased expression of SOCS2 mRNA CTD PMID:16415877 acetylsalicylic acid multiple interactions ISO RGD:1332166 6480464 butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine inhibits the reaction [Aspirin results in increased expression of SOCS2 mRNA], SOCS2 affects the reaction [Aspirin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]] CTD PMID:16415877 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of SOCS2 mRNA CTD PMID:28959563 afimoxifene increases expression ISO RGD:1352815 6480464 afimoxifene results in increased expression of SOCS2 mRNA CTD PMID:23373633 aflatoxin B1 affects expression ISO RGD:1352815 6480464 Aflatoxin B1 affects the expression of SOCS2 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:1352815 6480464 Aflatoxin B1 results in increased expression of SOCS2 mRNA CTD PMID:27153756 all-trans-4-oxoretinoic acid increases expression ISO RGD:1352815 6480464 4-oxoretinoic acid results in increased expression of SOCS2 mRNA CTD PMID:15982314 all-trans-retinoic acid decreases expression ISO RGD:1332166 6480464 Tretinoin results in decreased expression of SOCS2 mRNA CTD PMID:16788091 all-trans-retinoic acid increases expression ISO RGD:1352815 6480464 Tretinoin metabolite results in increased expression of SOCS2 mRNA, Tretinoin results in increased expression of SOCS2 mRNA CTD PMID:15982314 , PMID:21934132 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of SOCS2 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SOCS2 mRNA CTD PMID:16483693 antigen multiple interactions ISO RGD:1332166 6480464 deoxynivalenol inhibits the reaction [Antigens results in increased expression of SOCS2 mRNA], ochratoxin A inhibits the reaction [Antigens results in increased expression of SOCS2 mRNA] CTD PMID:28935500 antigen increases expression ISO RGD:1332166 6480464 Antigens results in increased expression of SOCS2 mRNA CTD PMID:28935500 antimycin A decreases expression ISO RGD:1352815 6480464 Antimycin A results in decreased expression of SOCS2 mRNA CTD PMID:33512557 azoxystrobin decreases expression ISO RGD:1352815 6480464 azoxystrobin results in decreased expression of SOCS2 mRNA CTD PMID:33512557 benzo[a]pyrene decreases expression ISO RGD:1332166 6480464 Benzo(a)pyrene results in decreased expression of SOCS2 mRNA CTD PMID:19770486 , PMID:32417428 benzo[a]pyrene decreases methylation ISO RGD:1352815 6480464 Benzo(a)pyrene results in decreased methylation of SOCS2 5' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1352815 6480464 Benzo(a)pyrene affects the methylation of SOCS2 3' UTR, Benzo(a)pyrene affects the methylation of SOCS2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1352815 6480464 Benzo(a)pyrene results in increased expression of SOCS2 mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:1332166 6480464 Benzo(a)pyrene results in increased expression of SOCS2 mRNA CTD PMID:21569818 benzoates increases expression ISO RGD:1352815 6480464 Benzoates analog results in increased expression of SOCS2 mRNA CTD PMID:29472718 beta-naphthoflavone increases expression ISO RGD:1332166 6480464 beta-Naphthoflavone results in increased expression of SOCS2 mRNA CTD PMID:15371557 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1332166 6480464 Diethylhexyl Phthalate results in decreased expression of SOCS2 mRNA CTD PMID:21318169 bisphenol A decreases expression ISO RGD:1352815 6480464 bisphenol A results in decreased expression of SOCS2 mRNA CTD PMID:16029874 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SOCS2 mRNA CTD PMID:30903817 , PMID:32145629 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SOCS2 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SOCS2 mRNA CTD PMID:25181051 cadmium atom increases expression ISO RGD:1352815 6480464 Cadmium results in increased expression of SOCS2 mRNA CTD PMID:21120746 cadmium dichloride increases expression ISO RGD:1352815 6480464 Cadmium Chloride results in increased expression of SOCS2 protein alternative form CTD PMID:33813002 calcitriol decreases expression ISO RGD:1352815 6480464 Calcitriol results in decreased expression of SOCS2 mRNA CTD PMID:16002434 calcitriol multiple interactions ISO RGD:1352815 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SOCS2 mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1352815 6480464 Calcitriol results in increased expression of SOCS2 mRNA CTD PMID:21592394 carbamazepine affects expression ISO RGD:1352815 6480464 Carbamazepine affects the expression of SOCS2 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1332166 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube multiple interactions ISO RGD:1332166 6480464 [Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of SOCS2 mRNA CTD PMID:25926378 carbon nanotube increases expression ISO RGD:1332166 6480464 Nanotubes, Carbon analog results in increased expression of SOCS2 mRNA CTD PMID:25620056 chlordecone decreases expression ISO RGD:1332166 6480464 Chlordecone results in decreased expression of SOCS2 mRNA CTD PMID:33711761 choline multiple interactions ISO RGD:1332166 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SOCS2 mRNA more ... CTD PMID:20938992 , PMID:33549593 ciguatoxin CTX1B affects expression ISO RGD:1332166 6480464 Ciguatoxins affects the expression of SOCS2 mRNA CTD PMID:18353800 cisplatin affects response to substance ISO RGD:1352815 6480464 SOCS2 protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin decreases expression ISO RGD:1352815 6480464 Cisplatin results in decreased expression of SOCS2 mRNA CTD PMID:27392435 cisplatin affects expression ISO RGD:1352815 6480464 Cisplatin affects the expression of SOCS2 mRNA CTD PMID:23300844 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of SOCS2 mRNA CTD PMID:22023808 clorgyline increases expression ISO RGD:1352815 6480464 Clorgyline results in increased expression of SOCS2 mRNA CTD PMID:19691856 copper atom decreases expression EXP 6480464 Copper results in decreased expression of SOCS2 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of SOCS2 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:1352815 6480464 Copper Sulfate results in increased expression of SOCS2 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1352815 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1352815 6480464 Asbestos, Crocidolite results in increased expression of SOCS2 mRNA CTD PMID:18687144 cyanocob(III)alamin multiple interactions ISO RGD:1332166 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SOCS2 mRNA CTD PMID:33549593 cycloheximide multiple interactions ISO RGD:1332166 6480464 Cycloheximide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of SOCS2 mRNA] CTD PMID:15371557 cycloheximide increases expression ISO RGD:1332166 6480464 Cycloheximide results in increased expression of SOCS2 mRNA CTD PMID:23237828 cyclosporin A increases expression ISO RGD:1352815 6480464 Cyclosporine results in increased expression of SOCS2 mRNA CTD PMID:20106945 , PMID:25562108 cyclosporin A decreases expression ISO RGD:1352815 6480464 Cyclosporine results in decreased expression of SOCS2 mRNA CTD PMID:27989131 cypermethrin multiple interactions ISO RGD:1332166 6480464 Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of SOCS2 mRNA] CTD PMID:31659573 cypermethrin decreases expression ISO RGD:1332166 6480464 cypermethrin results in decreased expression of SOCS2 mRNA CTD PMID:31659573 deguelin decreases expression ISO RGD:1352815 6480464 deguelin results in decreased expression of SOCS2 mRNA CTD PMID:33512557 deoxynivalenol increases expression ISO RGD:1332166 6480464 deoxynivalenol results in increased expression of SOCS2 mRNA CTD PMID:19625342 deoxynivalenol multiple interactions ISO RGD:1332166 6480464 deoxynivalenol inhibits the reaction [Antigens results in increased expression of SOCS2 mRNA] CTD PMID:28935500 dexamethasone increases expression ISO RGD:1332166 6480464 Dexamethasone results in increased expression of SOCS2 mRNA CTD PMID:22733784 dibenz[a,h]anthracene increases expression ISO RGD:1332166 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO RGD:1332166 6480464 Dibutyl Phthalate results in decreased expression of SOCS2 mRNA CTD PMID:17361019 , PMID:21266533 dicrotophos decreases expression ISO RGD:1352815 6480464 dicrotophos results in decreased expression of SOCS2 mRNA CTD PMID:28302478 diethylstilbestrol decreases expression ISO RGD:1332166 6480464 Diethylstilbestrol results in decreased expression of SOCS2 mRNA CTD PMID:15171707 disodium selenite multiple interactions ISO RGD:1332166 6480464 Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of SOCS2 mRNA] CTD PMID:31659573 dorsomorphin multiple interactions ISO RGD:1352815 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1352815 6480464 Doxorubicin results in decreased expression of SOCS2 mRNA CTD PMID:29803840 Enterolactone multiple interactions ISO RGD:1352815 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOCS2 mRNA CTD PMID:19167446 entinostat increases expression ISO RGD:1352815 6480464 entinostat results in increased expression of SOCS2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1352815 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOCS2 mRNA CTD PMID:27188386 enzalutamide decreases expression ISO RGD:1352815 6480464 enzalutamide results in decreased expression of SOCS2 mRNA CTD PMID:29581250 epoxiconazole affects expression ISO RGD:1332166 6480464 epoxiconazole affects the expression of SOCS2 mRNA CTD PMID:35436446 ethanol decreases expression ISO RGD:1332166 6480464 Ethanol results in decreased expression of SOCS2 mRNA CTD PMID:19167417 fenpyroximate decreases expression ISO RGD:1352815 6480464 fenpyroximate results in decreased expression of SOCS2 mRNA CTD PMID:33512557 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SOCS2 mRNA CTD PMID:24136188 , PMID:24793618 folic acid multiple interactions ISO RGD:1332166 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SOCS2 mRNA more ... CTD PMID:20938992 , PMID:33549593 folic acid decreases expression ISO RGD:1332166 6480464 Folic Acid results in decreased expression of SOCS2 mRNA CTD PMID:25629700 folpet decreases expression ISO RGD:1332166 6480464 folpet results in decreased expression of SOCS2 mRNA CTD PMID:31558096 formaldehyde increases expression ISO RGD:1352815 6480464 Formaldehyde results in increased expression of SOCS2 mRNA CTD PMID:23649840 formaldehyde decreases expression ISO RGD:1352815 6480464 Formaldehyde results in decreased expression of SOCS2 mRNA CTD PMID:28937961 gamma-hexachlorocyclohexane decreases expression EXP 6480464 Hexachlorocyclohexane results in decreased expression of SOCS2 mRNA CTD PMID:17785943 genistein increases expression ISO RGD:1332166 6480464 Genistein results in increased expression of SOCS2 mRNA CTD PMID:32186404 glycine betaine multiple interactions ISO RGD:1332166 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SOCS2 mRNA CTD PMID:33549593 glyphosate decreases expression ISO RGD:1352815 6480464 glyphosate results in decreased expression of SOCS2 mRNA CTD PMID:31295307 hexachlorobenzene affects expression EXP 6480464 Hexachlorobenzene affects the expression of SOCS2 mRNA CTD PMID:15159207 hexadecanoic acid multiple interactions ISO RGD:1352815 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of SOCS2 mRNA, [Palmitic Acid co-treated with Oleic Acid] results in increased expression of SOCS2 mRNA CTD PMID:30547786 isotretinoin increases expression ISO RGD:1352815 6480464 Isotretinoin results in increased expression of SOCS2 mRNA CTD PMID:15982314 L-methionine multiple interactions ISO RGD:1332166 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SOCS2 mRNA more ... CTD PMID:20938992 , PMID:33549593 leflunomide increases expression ISO RGD:1352815 6480464 leflunomide results in increased expression of SOCS2 mRNA CTD PMID:28988120 leflunomide increases expression ISO RGD:1332166 6480464 leflunomide results in increased expression of SOCS2 mRNA CTD PMID:19751817 lipopolysaccharide multiple interactions ISO RGD:1352815 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of SOCS2 mRNA] more ... CTD PMID:25725100 , PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:1332166 6480464 SOCS2 affects the reaction [Aspirin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]] CTD PMID:16415877 lipopolysaccharide increases expression ISO RGD:1332166 6480464 Lipopolysaccharides results in increased expression of SOCS2 mRNA CTD PMID:12057914 , PMID:22169119 lipopolysaccharide increases expression ISO RGD:1352815 6480464 Lipopolysaccharides results in increased expression of SOCS2 mRNA CTD PMID:25725100 , PMID:35811015 lipoxin A4 multiple interactions ISO RGD:1332166 6480464 AHR affects the reaction [lipoxin A4 results in increased expression of SOCS2 mRNA], butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine inhibits the reaction [lipoxin A4 results in increased expression of SOCS2 mRNA] CTD PMID:16415877 lipoxin A4 increases expression ISO RGD:1332166 6480464 lipoxin A4 results in increased expression of SOCS2 mRNA, lipoxin A4 results in increased expression of SOCS2 protein CTD PMID:16415877 maneb multiple interactions ISO RGD:1332166 6480464 [Maneb co-treated with Paraquat] results in increased expression of SOCS2 mRNA CTD PMID:36117858 mercury dibromide increases expression ISO RGD:1352815 6480464 mercuric bromide results in increased expression of SOCS2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1352815 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOCS2 mRNA CTD PMID:27188386 metacetamol decreases expression ISO RGD:1332166 6480464 3-hydroxyacetanilide results in decreased expression of SOCS2 mRNA CTD PMID:18544908 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of SOCS2 mRNA CTD PMID:22484513 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of SOCS2 mRNA CTD PMID:30047161 methylmercury chloride decreases expression ISO RGD:1352815 6480464 methylmercuric chloride results in decreased expression of SOCS2 mRNA CTD PMID:28001369 methylmercury(1+) increases expression EXP 6480464 methylmercury II results in increased expression of SOCS2 mRNA CTD PMID:17905399 monosodium L-glutamate decreases expression EXP 6480464 Sodium Glutamate results in decreased expression of SOCS2 mRNA, Sodium Glutamate results in decreased expression of SOCS2 protein CTD PMID:25697375 monosodium L-glutamate multiple interactions EXP 6480464 Sodium Glutamate inhibits the reaction [GH1 protein results in decreased expression of SOCS2 mRNA] more ... CTD PMID:25697375 N-nitrosodiethylamine multiple interactions EXP 6480464 [3 more ... CTD PMID:27048571 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of SOCS2 mRNA CTD PMID:25380136 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of SOCS2 mRNA CTD PMID:24136188 nickel atom increases expression ISO RGD:1352815 6480464 Nickel results in increased expression of SOCS2 mRNA CTD PMID:24768652 , PMID:25583101 niclosamide increases expression ISO RGD:1352815 6480464 Niclosamide results in increased expression of SOCS2 mRNA CTD PMID:36318118 obeticholic acid decreases expression ISO RGD:1352815 6480464 obeticholic acid results in decreased expression of SOCS2 mRNA CTD PMID:27939613 ochratoxin A multiple interactions ISO RGD:1332166 6480464 ochratoxin A inhibits the reaction [Antigens results in increased expression of SOCS2 mRNA] CTD PMID:28935500 oleic acid multiple interactions ISO RGD:1352815 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of SOCS2 mRNA, [Palmitic Acid co-treated with Oleic Acid] results in increased expression of SOCS2 mRNA CTD PMID:30547786 panobinostat multiple interactions ISO RGD:1352815 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOCS2 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1352815 6480464 panobinostat results in increased expression of SOCS2 mRNA CTD PMID:26272509 paracetamol decreases expression ISO RGD:1332166 6480464 Acetaminophen results in decreased expression of SOCS2 mRNA CTD PMID:18544908 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SOCS2 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1352815 6480464 Acetaminophen results in decreased expression of SOCS2 mRNA CTD PMID:21420995 paracetamol increases expression ISO RGD:1332166 6480464 Acetaminophen results in increased expression of SOCS2 mRNA CTD PMID:11264010 paraquat multiple interactions ISO RGD:1332166 6480464 [Maneb co-treated with Paraquat] results in increased expression of SOCS2 mRNA CTD PMID:36117858 PCB138 multiple interactions ISO RGD:1332166 6480464 [2 more ... CTD PMID:25510870 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1332166 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SOCS2 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SOCS2 mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of SOCS2 mRNA CTD PMID:19162173 , PMID:21318169 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of SOCS2 mRNA CTD PMID:31324951 phenobarbital affects expression ISO RGD:1352815 6480464 Phenobarbital affects the expression of SOCS2 mRNA CTD PMID:19159669 phenobarbital multiple interactions EXP 6480464 [3 more ... CTD PMID:27048571 phenylmercury acetate increases expression ISO RGD:1352815 6480464 Phenylmercuric Acetate results in increased expression of SOCS2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1352815 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOCS2 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1352815 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of SOCS2 mRNA CTD PMID:16979875 picoxystrobin decreases expression ISO RGD:1352815 6480464 picoxystrobin results in decreased expression of SOCS2 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:1332166 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of SOCS2 mRNA] CTD PMID:20059764 pirinixic acid decreases expression ISO RGD:1332166 6480464 pirinixic acid results in decreased expression of SOCS2 mRNA CTD PMID:11798191 more ... pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of SOCS2 mRNA CTD PMID:19162173 progesterone decreases expression ISO RGD:1352815 6480464 Progesterone results in decreased expression of SOCS2 mRNA CTD PMID:21768398 progesterone multiple interactions ISO RGD:1352815 6480464 [Estradiol co-treated with Progesterone] results in increased expression of SOCS2 mRNA, [Progesterone co-treated with TGFB1 protein] results in decreased expression of SOCS2 mRNA CTD PMID:20660070 , PMID:21768398 protein kinase inhibitor multiple interactions ISO RGD:1352815 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SOCS2 mRNA] CTD PMID:28003376 resveratrol decreases expression ISO RGD:1352815 6480464 resveratrol results in decreased expression of SOCS2 mRNA CTD PMID:19371625 resveratrol multiple interactions ISO RGD:1352815 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of SOCS2 mRNA CTD PMID:19167446 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of SOCS2 mRNA CTD PMID:28374803 rotenone decreases expression ISO RGD:1352815 6480464 Rotenone results in decreased expression of SOCS2 mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1352815 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of SOCS2 mRNA] CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1352815 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1352815 6480464 Silicon Dioxide analog results in increased expression of SOCS2 mRNA CTD PMID:25895662 sodium arsenite decreases expression ISO RGD:1352815 6480464 sodium arsenite results in decreased expression of SOCS2 mRNA CTD PMID:25493608 sodium arsenite multiple interactions ISO RGD:1332166 6480464 [Dietary Fats co-treated with sodium arsenite] results in decreased expression of SOCS2 mRNA CTD PMID:28283972 sodium arsenite decreases expression ISO RGD:1332166 6480464 sodium arsenite results in decreased expression of SOCS2 mRNA CTD PMID:28283972 sodium arsenite increases expression ISO RGD:1352815 6480464 sodium arsenite results in increased expression of SOCS2 mRNA CTD PMID:21281968 , PMID:34032870 sodium arsenite affects methylation ISO RGD:1352815 6480464 sodium arsenite affects the methylation of SOCS2 gene CTD PMID:28589171 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of SOCS2 mRNA CTD PMID:25993096 sotorasib multiple interactions ISO RGD:1352815 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SOCS2 mRNA CTD PMID:36139627 starch multiple interactions EXP 6480464 Starch analog inhibits the reaction [Rapeseed Oil metabolite results in increased expression of SOCS2 mRNA] CTD PMID:27363782 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of SOCS2 mRNA CTD PMID:30047161 sulfasalazine decreases expression ISO RGD:1332166 6480464 Sulfasalazine results in decreased expression of SOCS2 mRNA CTD PMID:31830553 sunitinib increases expression ISO RGD:1352815 6480464 Sunitinib results in increased expression of SOCS2 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1332166 6480464 Tamoxifen affects the expression of SOCS2 mRNA CTD PMID:20937368 tebufenpyrad decreases expression ISO RGD:1352815 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of SOCS2 mRNA CTD PMID:33512557 temozolomide increases expression ISO RGD:1352815 6480464 Temozolomide results in increased expression of SOCS2 mRNA CTD PMID:31758290 testosterone decreases expression ISO RGD:1332166 6480464 Testosterone results in decreased expression of SOCS2 mRNA CTD PMID:15788153 testosterone increases expression ISO RGD:1352815 6480464 Testosterone results in increased expression of SOCS2 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1352815 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SOCS2 mRNA CTD PMID:21592394 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SOCS2 mRNA CTD PMID:23411599 trametinib multiple interactions ISO RGD:1352815 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SOCS2 mRNA CTD PMID:36139627 trichloroethene increases expression ISO RGD:1332166 6480464 Trichloroethylene results in increased expression of SOCS2 mRNA CTD PMID:28973375 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of SOCS2 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1352815 6480464 trichostatin A results in increased expression of SOCS2 mRNA CTD PMID:24935251 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of SOCS2 mRNA CTD PMID:30589522 triptonide increases expression ISO RGD:1332166 6480464 triptonide results in increased expression of SOCS2 mRNA CTD PMID:33045310 trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of SOCS2 mRNA CTD PMID:24136188 trovafloxacin multiple interactions ISO RGD:1332166 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SOCS2 mRNA CTD PMID:18930950 tunicamycin decreases expression ISO RGD:1332166 6480464 Tunicamycin results in decreased expression of SOCS2 mRNA CTD PMID:17127020 tunicamycin increases expression ISO RGD:1352815 6480464 Tunicamycin results in increased expression of SOCS2 mRNA CTD PMID:29453283 urethane decreases expression ISO RGD:1352815 6480464 Urethane results in decreased expression of SOCS2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1332166 6480464 Valproic Acid affects the expression of SOCS2 mRNA CTD PMID:17292431 valproic acid decreases expression ISO RGD:1352815 6480464 Valproic Acid results in decreased expression of SOCS2 mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:1352815 6480464 Valproic Acid affects the expression of SOCS2 mRNA CTD PMID:25979313 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of SOCS2 mRNA CTD PMID:21318169 valproic acid decreases expression ISO RGD:1332166 6480464 Valproic Acid results in decreased expression of SOCS2 mRNA CTD PMID:21427059 vancomycin decreases expression ISO RGD:1332166 6480464 Vancomycin results in decreased expression of SOCS2 mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of SOCS2 mRNA CTD PMID:19015723 zinc atom multiple interactions ISO RGD:1352815 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SOCS2 mRNA, [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of SOCS2 mRNA CTD PMID:16979875 , PMID:18593933 zinc atom multiple interactions ISO RGD:1332166 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SOCS2 mRNA CTD PMID:33549593 zinc atom decreases expression ISO RGD:1352815 6480464 Zinc deficiency results in decreased expression of SOCS2 mRNA CTD PMID:22171008 zinc sulfate increases expression ISO RGD:1352815 6480464 Zinc Sulfate results in increased expression of SOCS2 mRNA CTD PMID:16330358 zinc(0) multiple interactions ISO RGD:1352815 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SOCS2 mRNA, [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of SOCS2 mRNA CTD PMID:16979875 , PMID:18593933 zinc(0) decreases expression ISO RGD:1352815 6480464 Zinc deficiency results in decreased expression of SOCS2 mRNA CTD PMID:22171008 zinc(0) multiple interactions ISO RGD:1332166 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SOCS2 mRNA CTD PMID:33549593